{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-019905","form_type":"8-K","ticker":"VICP","cik":"0001468639","company_name":"Vicapsys Life Sciences, Inc.","filed_at":"2023-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.956956+00:00","generated_at":"2026-06-14T08:07:58.641088+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Vicapsys Life Sciences amends patent license with Massachusetts General Hospital, adding new patent rights","bullets":["Ninth Amendment adds Patent Rights MGH 24644 (PCT/US2018/051950) to exclusive license.","Company must submit a research and development plan for new patent rights within one year.","Company pays $2,000 non-refundable license fee and reimburses $3,956 in patent costs by July 31, 2023.","Amendment updates diligence requirements under Section 3.1 of the original 2013 agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-019905","json":"https://secwatch.observer/filing/0001493152-23-019905.json","markdown":"https://secwatch.observer/filing/0001493152-23-019905.md","text":"https://secwatch.observer/filing/0001493152-23-019905.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/0001493152-23-019905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T08:07:58.641088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05dff5c752a47e796c6b9ff70a762738c8508ba0","claim":"Vicapsys Life Sciences, Inc. amended Ninth Amendment to the Exclusive Patent License Agreement with The General Hospital Corporation d/b/a Massachusetts General Hospital (effective 2023-03-31).","evidence_excerpt":"On March 31, 2023, Vicapsys Life Sciences, Inc.(the “Company”) and The General Hospital Corporation d/b/a Massachusetts General Hospital (the “Hospital”) entered into a Ninth Amendment to the Exclusive Patent License Agreement (the “Ninth Amendment”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/0001493152-23-019905-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"The General Hospital Corporation d/b/a Massachusetts General Hospital"},{"label":"Effective","value":"2023-03-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}